Co-Authors
This is a "connection" page, showing publications co-authored by Karim Dorgham and Guy Gorochov.
Connection Strength
3.619
-
Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol. 2021 06; 147(6):2098-2107.
Score: 0.941
-
Considering Personalized Interferon Beta Therapy for COVID-19. Antimicrob Agents Chemother. 2021 03 18; 65(4).
Score: 0.935
-
Tocilizumab in COVID-19 therapy: who benefits, and how? Lancet. 2021 07 24; 398(10297):299-300.
Score: 0.240
-
IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021 01 20; 13(577).
Score: 0.229
-
Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope. J Immunol Res. 2019; 2019:9804584.
Score: 0.204
-
Synergistic convergence of microbiota-specific systemic IgG and secretory IgA. J Allergy Clin Immunol. 2019 04; 143(4):1575-1585.e4.
Score: 0.200
-
Microbial ecology perturbation in human IgA deficiency. Sci Transl Med. 2018 05 02; 10(439).
Score: 0.191
-
Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display. Methods Enzymol. 2016; 570:47-72.
Score: 0.161
-
CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients. JCI Insight. 2021 09 22; 6(18).
Score: 0.061
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
Score: 0.060
-
Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption. Am J Respir Crit Care Med. 2021 06 01; 203(11):1433-1435.
Score: 0.059
-
Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 May 10; 12(1):2824.
Score: 0.059
-
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia. J Clin Immunol. 2021 04; 41(3):536-544.
Score: 0.058
-
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 02 08; 12(1):844.
Score: 0.058
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.057
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.057
-
Assessment of an ultra-sensitive IFN? immunoassay prototype for latent tuberculosis diagnosis. Eur Cytokine Netw. 2018 Nov 01; 29(4):136-145.
Score: 0.050